Muñoz M, Cobos A, Campos A, Ariza D, Muñoz E, Gómez A
Department of Clinical Chemistry, GIEMSA, School of Medicine, Univeristy of Malaga, Malaga, Spain.
Acta Anaesthesiol Scand. 2005 Sep;49(8):1182-90. doi: 10.1111/j.1399-6576.2005.00765.x.
In patients undergoing total knee replacement (TKR) most blood loss occurs postoperatively and return of unwashed filtered shed blood (USB) from postoperative drainage may represent an alternative to allogeneic blood transfusion (ABT). We evaluated the impact of USB return, with or without leucocytes, on the acute-phase response (APR) after TKR.
Forty-eight TKR patients, intended to receive postoperative USB, entered the study. Blood samples were obtained before and 6, 24, 72 h and 7 days after surgery, and from the USB before and after it passed through a 40-microm filter (Group F40) or a leucocyte-reduction filter (Group LRF). Haematimetric parameters, APR proteins (albumin, prealbumin, ceruloplasmin, haptoglobin, C-reactive protein), complement C3 and C4, and cytokines (IL-1beta, IL-6, IL-8, IL-10, and TNF-alpha) were measured in all samples.
Twenty-eight patients (Group F40=14, Group LRF=14) received a mean of 1.2 USB units, without any clinically relevant incident, and did not need additional ABT. Sixteen out of the 20 remaining patients who received neither USB nor ABT served as a control group for the postoperative APR study. All patients showed the typical postoperative APR profile and there were no significant differences between groups for APR parameters, postoperative complications, or hospital stay.
Postoperative blood salvage and return, with or without a LRF, after TKR does not present any clinically relevant side-effects and does not modify APR induced by surgery. These findings seem to confirm the clinical experience that postoperative USB return is safe and questions the beneficial effect of using LRF.
在接受全膝关节置换术(TKR)的患者中,大部分失血发生在术后,术后引流液中未洗涤过滤的回收失血(USB)可能是同种异体输血(ABT)的一种替代方法。我们评估了有无白细胞的USB回输对TKR术后急性期反应(APR)的影响。
48例拟接受术后USB回输的TKR患者进入本研究。在手术前、术后6、24、72小时及7天采集血样,并在USB通过40微米过滤器之前和之后(F40组)或通过白细胞滤除器之后(LRF组)采集血样。对所有样本测量血液学参数、APR蛋白(白蛋白、前白蛋白、铜蓝蛋白、触珠蛋白、C反应蛋白)、补体C3和C4以及细胞因子(IL-1β、IL-6、IL-8、IL-10和TNF-α)。
28例患者(F40组=14例,LRF组=14例)平均接受了1.2单位的USB回输,未发生任何临床相关事件,且无需额外的ABT。其余20例既未接受USB回输也未接受ABT的患者中有16例作为术后APR研究的对照组。所有患者均呈现典型的术后APR特征,各APR参数、术后并发症或住院时间在各组间无显著差异。
TKR术后回收血液并回输,无论是否使用白细胞滤除器,均未出现任何临床相关的副作用,也未改变手术诱导的APR。这些发现似乎证实了术后USB回输是安全的临床经验,并对使用白细胞滤除器的有益效果提出了质疑。